Skandinaviska Enskilda Banken Ab (Publ) Ideaya Biosciences, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $21.5 Billion
- Q3 2024
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 32,544 shares of IDYA stock, worth $903,746. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,544
Previous 32,544
-0.0%
Holding current value
$903,746
Previous $1.14 Million
9.81%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding IDYA
# of Institutions
216Shares Held
80.8MCall Options Held
69KPut Options Held
20K-
Black Rock Inc. New York, NY6.81MShares$189 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.21MShares$145 Million0.38% of portfolio
-
Janus Henderson Group PLC London, X05.16MShares$143 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.8MShares$133 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.02MShares$112 Million0.01% of portfolio
About IDEAYA Biosciences, Inc.
- Ticker IDYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,067,700
- Market Cap $1.33B
- Description
- IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...